Addiction Medicine
Latest News
Could semaglutide treat addiction as well as obesity?
“I would say, overall, the jury is still out,” as to whether anecdotal reports of GLP-1 agonists curbing addictions will be borne out in...
From the Journals
Alcohol dependence in teens tied to subsequent depression
There was no evidence that frequency or quantity of alcohol consumption at age 18 was significantly associated with depression at age 24.
Conference Coverage
Higher buprenorphine doses help OUD patients stay in treatment
Opioid users stick around when they get more withdrawal relief, addiction clinic finds.
Conference Coverage
Buprenorphine update: Looser rules and a helpful injectable
As overdose epidemic continues, new regulations change landscape for opioid addiction therapy.
Latest News
Exercise and empathy can help back pain patients in primary care
Recent research suggests limited pain relief from analgesics and antidepressants, but patients report that doctors’ behavior makes a difference in...
News from the FDA/CDC
FDA approves buprenorphine injection for opioid use disorder
Brixadi is approved in both weekly and monthly subcutaneous injectable formulations at varying doses.
News from the FDA/CDC
Overdose deaths mark another record year, but experts hopeful
“But these numbers are still extraordinarily high. We shouldn’t suggest the crisis is in any way over.”
News from the FDA/CDC
FDA moves to curb misuse of ADHD meds
The boxed warning will also advise heath care professionals to monitor patients closely for signs and symptoms of misuse, abuse, and addiction.
Guidance for Practicing Primary Care
Thoughts on the CDC update on opioid prescribing guidelines
While the guidelines do a great job recommending how to prescribe opioids, they do not go into any depth discussing other treatment options.
From the Journals
Young men at highest schizophrenia risk from cannabis abuse
For young men aged 21-30, the proportion of preventable schizophrenia cases related to cannabis abuse disorder may be as high as 30%.
From the Journals
Why is buprenorphine use flatlining?
“Clinicians are not maximizing opportunities to initiate buprenorphine treatment among patients with opioid addiction,” Dr. Kao-Ping Chua said.